Abstract Background Coronavirus disease 2019 (COVID-19) has evolved into a worldwide
pandemic, and has been found to be closely associated with mental and neurological …

The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with
neurodegenerative diseases and the specific neurological manifestations of COVID-19 have …

Aims We conducted a systematic review and meta-analysis to assess various antidiabetic
agents' association with mortality in patients with type 2 diabetes (T2DM) who have …

Objective The present study aimed to perform a systematic review and meta-analysis on the
prevalence of one-year hospital readmissions and post-discharge all-cause mortality in …

Aims GLP-1RA has many beneficial properties, including anti-inflammatory, anti-
obesogenic, pulmonary protective effects as well as beneficial impact on gut microbiome …

This study assessed fear of the novel coronavirus-2019 (COVID-19), preventive COVID-19
infection behaviors, and the association between fear of COVID-19 and preventive COVID …

Ivermectin is an FDA‐approved drug for a parasitic disease that has broad antiviral activity.
This study aims to analyse the efficacy of ivermectin in improving the Covid‐19 outcomes …

Vitamin D has many protective properties and potential role against acute lung injury. Low
serum vitamin D is associated with high risk of pneumonia and development of acute …

The severity of coronavirus disease 2019 (COVID-19) ranges from mild to death, with high
morbidity and mortality rates reported amongst a vulnerable subset of patients termed high …

Background Currently, JAK-inhibitors are repurposed for therapy of Covid-19 because of
their ability in restraining immune response, yet the corroboration regarding their advantage …